European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012)
By J. Perk, G. Backer, H. Gohlke, I. Graham, Željko Reiner, W. Verschuren, C. Albus, P. Benlian, G. Boysen, R. Cífková and 18 more. International Journal of Behavioral Medicine, 2012
7,457 citations recorded by the source corpus.
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) : the Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts).
Subfields: Cardiology and Cardiovascular Medicine, Public Health, Environmental and Occupational Health
View Paper: https://www.semanticscholar.org/paper/a40212b1bef1390083e1ae3a5e37978c410e26d4
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
- Gary S. Collins
- Karel G. M. Moons
- Douglas G. Altman
- Philippe van de Borne
- Joris A. H. de Groot
- S. Laurent
- Jeroen J. Bax
- I. Graham
In Public Health, Environmental and Occupational Health
- Gary S. Collins
- Karel G. M. Moons
- Douglas G. Altman
- H. Boeing
- J. Armitage
- Yaakov Stern
- I. Graham
- T. Ivanova
Citations in the corpus
- 2016 European Guidelines on cardiovascular disease prevention in clinical practice (2016, background): “There were several problems with this chart, which are outlined in the Fourth Joint European Guidelines on prevention.(11,29) This led to the presently recommended SCORE system, estimating an individual’s 10 year risk of fatal CVD.”
- 2013 ESH/ESC Guidelines for the management of arterial hypertension (2007, background): “Az utóbbi idôben, a European Guidelines on CVD Prevention cukorbetegeknek <140/80 Hgmm célértéket javasolt [50].”
- Clinical diagnosis of Alzheimer’s disease: recommendations of the International Working Group (2021, background): “We anticipate the emergence of age-and risk factor-adjusted individualized predictions and the ability to rank the risk by analogy with the example of cardiovascular risk factors 32 .”